Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.480
-0.100 (-3.88%)
Dec 4, 2025, 3:56 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 961.6 million as of December 3, 2025. Its market cap has increased by 41.75% in one year.
Market Cap
961.60M
Enterprise Value
1.50B
Revenue
627.22M
Ranking
n/a
PE Ratio
171.28
Stock Price
2.48
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 961.60M, an increase of 264.56%. That is a compound annual growth rate of 13.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 961.60M | -11.12% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | 861.69M | 15.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.68B |
| Pro Medicus | 27.39B |
| Cochlear | 18.00B |
| Sonic Healthcare | 11.53B |
| Ramsay Health Care | 8.57B |
| Ansell | 5.37B |
| Telix Pharmaceuticals | 5.10B |
| Mesoblast | 3.43B |